loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of chemical intermediates, fine chemicals supplied/manufactured by Polpharma

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 1-methyl-2-pyrrolidineethanol (1)

02 2,3,5-trichlorobenzaldehyde (1)

03 2-(2-chloroethyl)-1-methylpyrrolidine hydrochloride (1)

04 4-hydroxybenzyl alcohol (1)

05 8-hydroxyquinaldine (1)

06 N-(p-toluenesulfonyl)-l-glutamic acid (1)

07 Potassium ethyl carbonate (1)

filter

01 4-Hydroxybenzoic Acid (1)

02 Azelastine Hydrochloride (1)

03 Bisoprolol Fumarate (1)

04 Chlorquinaldol (1)

05 Clemastine (1)

06 Levamisole (1)

07 Octenidine Hydrochloride (1)

filter

01 22719-67-1 (1)

02 4816-80-2 (1)

03 56824-22-7 (1)

04 56961-75-2 (1)

05 623-05-2 (1)

06 67004-64-2 (1)

07 826-81-3 (1)

67004-64-2
Clemastine
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
56961-75-2
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
56824-22-7
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
623-05-2
Bisoprolol Fumarate
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
826-81-3
Chlorquinaldol
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
4816-80-2
Levamisole
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
22719-67-1
4-Hydroxybenzoic Acid
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's ...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
Post Enquiry
POST ENQUIRY